SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-19-040597
Filing Date
2019-07-17
Accepted
2019-07-16 17:42:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a19-12882_3sc13da.htm SC 13D/A 47419
  Complete submission text file 0001104659-19-040597.txt   48739
Mailing Address C/O ALPHASIMPLEX GROUP, LLC ONE CAMBRIDGE CENTER, 9TH FLOOR CAMBRIDGE MA 02142
Business Address
Lo Andrew (Filed by) CIK: 0001679076 (see all company filings)

Type: SC 13D/A

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB (441) 295-5950
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-89732 | Film No.: 19957851
SIC: 2834 Pharmaceutical Preparations